Rula is a leading company in the behavioral healthcare space, with a mission to make mental healthcare work for everyone
Rula is a leading company in the behavioral healthcare space, with a mission to make mental healthcare work for everyone.
Clinics/Outpatient Services📍 Santa Clara, CAFounded 2019
Current Valuation
$1.3B
as of 2024-Q3
UNICORN
QL Price
$879.41M
-30% vs last round
QuantLogix's current estimate for Rula, published 2026-09-15 — below the last disclosed round of $1.3B (2024-Q3).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$1.3B
2024-Q3
weight 0.26
Secondary market print
$725M
2026-06-27
weight 0.62
How this price has held up
No round has priced for Rula since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-15 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Rula, 2026-09-15 (961259e299271ab3).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Rula going public?
No. Rula is private and has not filed to go public. There is no S-1 on file.
What is Rula's valuation in 2026?
Rula is valued at $1.3B as of 2024-Q3, set by its Series B ($125M, Jul 2024). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Rula filed an S-1?
No public S-1 is on file for Rula.
Can you buy Rula stock?
No. Rula is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Rula on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2019
HQ
Santa Clara, CA
Employees
103
Total Raised
$110.9M
Last Round
Series B — $125M (Jul 2024)
IPO Status
private
Fundraising Status
Series B · $125M · 2y 2mo ago
privateTotal raised $110.9M
Secondary Market
Implied price / share
$3.35
Last round price / share
$5.78
vs last round
-42.0%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series B
$125M
Jul 2024
—
$1.3B
Talent Signal
Hiring trend
● First snapshot
trend accrues with monthly sweeps
Open roles
40
via ashby
Product-build share
40%
engineering, research, product, design
Trajectory
steady
balanced build + GTM — 40% builders vs 60% go-to-market/G&A — scaling both sides.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Sr. Staff AI Engineer - Applied AI (Remote)Sr. Software Engineer - Provider Access (Remote)Staff AI Engineer - Foundation (Remote)Sr. Product Manager - Core Experience (Remote) Sr. Analytics Engineer (Remote)Senior Staff Software Engineer (Remote)
Counted from Rula's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Health Care
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q3. Refreshed quarterly.